HOME >> BIOLOGY >> NEWS
Coils slash death/disabilty from brain aneurysms

Preliminary results of a long-term study suggest that coils inserted into burst aneurysms in the brain decrease by 25 percent the risk of patient death and disability during the first year after the procedure, according to a report published in the October 26 issue of The Lancet. Aneurysms are abnormal ballooning of artery walls.

"The results with coiling were so favorable the trial was ended ahead of schedule," says Kieran Murphy, M.D., the primary investigator for the study at Hopkins and associate professor of radiology and neurological surgery.

The study, called the International Subarachnoid Aneurysm Trial (ISAT), examined patients at 44 medical centers in Europe, Australia and North America whose aneurysms were suitable for treatment with either surgical clipping or coiling. Those with aneurysms shaped in such a manner that prevented the retention of the coils as well as those for whom surgical clipping was not possible, were excluded from the study. Of 2,143 patients for whom both treatments were appropriate, 1,073 were randomly selected to receive the coils, and 1,070 were chosen to undergo surgical clipping.

Surgical clipping, currently the most commonly used treatment for brain aneurysms, requires opening the skull and placing a metal clip across the neck of the aneurysm to stop the bleeding. In coiling, a catheter is inserted through an artery in the leg up into the brain to fill the aneurysm there with tiny platinum coils.

The coils are like "miniature slinkies that are folded gently into the aneurysm like a ball of yarn one by one to stop the bleeding," says Murphy. Noting that the procedure also can be used to prevent aneurysms from bursting, he adds, "With coiling, we can either help fix the damage or prevent it from occurring."

Murphy likens brain aneurysms to ticking time bombs. "They can lurk for years without causing symptoms. Then, without warning, they can burst, spilling blood into the brain wit
'"/>

Contact: Gary Stephenson
gstephenson@jhmi.edu
410-955-5384
Johns Hopkins Medical Institutions
24-Oct-2002


Page: 1 2

Related biology news :

1. Trial shows which brain cancer patients benefit from temozolomide
2. Targeted therapy knocks out pediatric brain cancer in mice
3. New way to protect brain from stroke damage
4. Chemical signals health of brain cells Symposium
5. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
6. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
7. Genetic clues found for common congenital brain disorder
8. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
9. Molecular therapeutics advance fight against brain cancer
10. Depression traced to overactive brain circuit
11. Clusters of alterations on PIK3CA gene found in brain cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: